Q2 FY27 Earnings Call Transcript Filed
CCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Smallcap 250 and 2.8 pts less than its Tea & Coffee peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CCL Products filed Q2 FY27 earnings call transcript. Q2 group revenue at INR1,216 crores, up 7.8% value with double-digit volume growth. Q2 EBITDA grew 9.5% to INR217 crores, net profit jumped 29% to INR130 crores. H1 EBITDA up 15% and net profit up 42% to INR247 crores. Management maintained full year guidance of around 15% volume and similar EBITDA growth, noting Q3 and Q4 order book looks robust. Domestic branded business growing 25%. Gross debt at INR1,192 crores, within guided range. FD capacity nearing full utilisation in 1-1.5 years; expansion decision likely by Q4 FY27.
Reaffirmed 15% volume and EBITDA growth guidance for FY27 with strong Q3-Q4 order pipeline. FD capacity expansion decision expected by Q4 FY27.